Explore

Your selections: Mental Health > Depression
Understanding how the anesthetic and club drug works ushered in a paradigm shift for depression and mental health.
  • BrainFacts/SfN
For years, anecdotal reports suggested microdosing can improve mood and reduce depression and anxiety. Now, scientists are trying to figure out whether it’s all hype, a salve for our unhappiness, or something in between.
  • BrainFacts/SfN
As physicians attempt to identify mental illness, they face a diagnostic system that includes nearly 300 disorders. To improve the system, researchers look into genetics.
  • BrainFacts/SfN
And other neuroscience news for the week of February 10, 2020.
  • BrainFacts/SfN
Neuroscience research is advancing what we know about depression, and helping us develop treatments for it.
  • BrainFacts/SfN
The risks of antidepressants during pregnancy are minimal — and they pale in comparison to the risks of not treating depression.
  • BrainFacts/SfN
The first new antidepressant medication in decades, ketamine is a game changer for depression treatment.
  • BrainFacts/SfN
  • 5 min
Around the world, women are more likely than men to be diagnosed with depression.
  • BrainFacts/SfN
AI programs assist clinicians in surfacing signs of depression through patient data.
  • BrainFacts/SfN
The fast-acting drug offers a new way to treat depression and fathom its origins. Recent approval of a nasal spray promises to expand access, but much remains unknown.
  • Knowable Magazine
Chance observations in the 1950s prompted scientists to hypothesize that low neurotransmitter levels cause depression. That thinking has unraveled.
  • Knowable Magazine
Serendipitous findings in the 1950s spawned the idea that depression was a “chemical imbalance” in the brain. But decades of research — and a radical new treatment — are upending that thinking.
  • BrainFacts/SfN